**9. References**


Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy,

Electronic ISSN: 1552-4604.

Electronic ISSN 1097-6825.

7484, Electronic ISSN 0098-3598.

ISSN 0091-6749, Electronic ISSN 1097-6825.

9995.

6137.

1321-1330, Print ISSN 0003-4738.

Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy 103

Brooks CD, Karl KJ, Francom SF. Oral methylprednisolone acetate (Medrol Tablets) for

Brown EB, Seideman T, Siegelaub BA, Popovitz FACA. Depomethylprednisolone in the

Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic

(1992) *Drugs*, Vol.43, No.5 (May 1992), pp. 760-775, Print ISSN 0012-6667. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz, et al.

Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection

Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, et al. Use of anti-

Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, et al. Omalizumab

Chen S T, Lu K H, Sun H L, Chang W T, Lue K H and Chou M C. Randomized placebo-

(February 2006), pp. 49-54, Print ISSN 0905-6157, Electronic ISSN 1399-3038. Chervinsky P, Casale TB, Townley R, Tripathy I, Hedgecock S, Fowler-Taylor A, et al.

Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P. Use of montelukast alone

2003), pp. 160-167, Print ISSN 1081-1206, Electronic ISSN 1534-4436. Chu SY, Horton HM, Pong E, Leung IW, Chen H, Nguyen DH, et al. Reduction of total IgE

seasonal rhinitis: examination of dose and symptom response. (1993) *J Clin Pharmacol*, Vol.33, No.9 (September 1993), pp. 816-822, Print ISSN: 0091-2700,

treatment of ragweed hay fever. (1960) *Ann Allergy*, Vol.18, No.1 (January 1960), pp.

and pharmacokinetic properties, and therapeutic potential in allergic rhinitis.

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. (2004) *Allergy*, Vol.59, No.5 (May 2004), pp. 498–504, Print ISSN 0105-4538, Electronic ISSN 1398-

immunotherapy for seasonal allergic rhinitis. (2007) *Cochrane Database Syst Rev*, Vol.24, No.1 (January 2007): CD001936, Print ISSN 1469-493X, Linking ISSN 1361-

IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. (1997) *J Allergy Clin Immunol*, Vol.100, No.1 (July 1997), pp. 110-121, Print ISSN 0091-6749,

pretreatment decreases acute reactions after rush immunotherapy for ragweedinduced seasonal allergic rhinitis. (2006) *J Allergy Clin Immunol*, Vol.117, No.1 (January 2006), pp. 134–140, Print ISSN 0091-6749, Electronic ISSN 1097-6825. Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, et al. Effect of

omalizumab on symptoms of seasonal allergic rhinitis. A randomized controlled trial. (2001) *JAMA*, Vol.286, No.23 (December 2001), pp. 2956-2967, Print ISSN 0098-

controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. (2006) *Pediatr Allergy Immunol*, Vol.17, No.1

Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. (2003*) Ann Allergy Asthma Immunol*, Vol.91, No.2 (August

by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody. (2012) *J Allergy Clin Immunol*, 2012 Jan 16. [Epub ahead of print], Print

or in combination with desloratadine or levocetirizine in patients with persistent


Allen DB. Systemic effects of intranasal steroids: an endocrinologist's perspective. (2000) *J* 

Barnes PJ. New drugs for asthma. (1992) *Eur Respir J*, Vol.5, No.9 (October 1992), pp. 1126-

Baroody FM, Shenaq D, DeTineo M, Wang J, Naclerio RM. Fluticasone furoate nasal spray

(June 2009), pp. 1342-1348, Print ISSN0091-6749, Electronic ISSN 1097-6825. Baumann D, Bachert C, Högger P. Dissolution in nasal fluid, retention and anti-

Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P. The role of mometasone furoate

Bez C, Schubert R, Kopp M, Ersfeld Y, Rosewich M, Kuehr J, et al. Effect of anti-

Bjermer L, Diamant Z. Current and emerging nonsteroidal anti-inflammatory therapies

Borish L. Allergic rhinitis: systemic inflammation and implications for management. (2003) *J* 

Borum P, Grønborg H, Mygind N. Seasonal allergic rhinitis and depot injection of a

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T et al.

Bousquet J, Van Cauwenberge P, Khaltaev N; ARIA Workshop Group; World Health

Bronsky EA, Druce H, Findlay SR, Hampel FC, Kaiser H, Ratner P, et al. A clinical trial of

1136, Print ISSN: 0903-1936, Electronic ISSN: 1399-3003.

Print ISSN 0954-7894, Electronic ISSN 1365-2222.

0091-6749, Electronic ISSN 1097-6825.

No.4 (July-August 2004), pp. 235-246, Print ISSN 1176-3450.

pp. 26-32, Print ISSN 0105-4538, Electronic ISSN: 1398-9995.

0091-6749, Electronic ISSN 1097-6825.

Electronic ISSN 1365-2222.

1098-4275.

1398-9995.

Electronic ISSN 1097-6825.

ISSN 0091-6749, Electronic ISSN 1097-6825.

*Allergy Clin Immunol*, Vol.106, No.4 Suppl (October 2000), pp. S179-S190, Print ISSN

reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. (2009) *J Allergy Clin Immunol*, Vol.123, No.6

inflammatory activity of fluticasone furoate in human nasal tissue ex vivo. (2009) *Clin Exp Allergy*, Vol.39, No.10 (October 2009), pp. 1540-1550, Print ISSN 0954-7894,

aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. (2007) *Pediatrics*, Vol.119, No.6 (June 2007), pp. e1392–e1397, Print ISSN 0031-4005, Electronic ISSN

immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis. (2004) *Clin Exp Allergy*, Vol.34, No.7 (July 2004), pp. 1079–1085,

targeting specific mechanisms in asthma and allergy. (2004) *Treat Respir Med*, Vol.3,

*Allergy Clin Immunol*, Vol.112, No.6 (December 2003), pp. 1021-1031, Print ISSN

corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording. (1987) *Allergy*, Vol.42, No.1 (January 1987),

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Heatlth Organization, GA(2)LEN and AllergGen). (2008) *Allergy*, Vol.63, No.86 Suppl (April 2008), pp. 8-160, Print ISSN 0105-4538, Electronic ISSN

Organization. ARIA workshop group. World Health Organization. Allergic Rhinitis and its impact on asthma Workshop Report. (2001) *J Allergy Clin Immunol*, Vol.108, No.5 Suppl (November 2001), pp. S147-S334, Print ISSN 0091-6749,

ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. (1995) *J Allergy Clin Immunol*, Vol.95, No.5 Pt 2 (May 1995), pp. 1117-1122, Print


Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy,

269, Print ISSN 0959-8138.

Electronic ISSN 1578-1267.

Electronic ISSN 1879-114X.

Electronic ISSN 1399-3038.

ISSN 0114-5916.

1398-9995.

4877.

Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy 105

Ganderton MA, James VH. Clinical and endocrine side-effects of methylprednisolone

Gawchik SM, Saccar CL. A risk-benefit assessment of intranasal triamcinolone acetonide in

GlaxoSmithKline. Ficha técnica de Avamys©. GlaxoSmithKline 2008. Revised: 11/11/2011. Gozalo F, Martin S, Rico P, Alvarez E, Cortes C. Clinical efficacy and tolerance of two year

Hedner P, Persson G. Suppression of the hypothalamic-pituitary-adrenal axis after a single

Horan JD, Johnson JD. Flunisolide nasal spray in the treatment of perennial rhinitis. (1978) *Can Med Assoc J*, Vol.119, No.4 (August 1978), pp. 334-338, Print ISSN 0008-4409. Howland WC 3rd. Fluticasone propionate: topical or systemic effects? (1996) *Clin Exp Allergy*,

Howland WC 3rd, Hampel FC jr, Martin BG, Ratner PH, van Bavel JH, Field EA. The efficacy

International Rhinitis Management Working Group. International Consensus Report on the

Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S, et al.

Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, et al. Long-

Kamin W, Kopp MV, Erdnuess F, Schauer U, Zielen S, Wahn U. Safety of anti-IgE treatment

1994), pp.1-34, Print ISSN 0105-4538, Electronic ISSN: 1398-9995.

Print ISSN 0091-6749, Electronic ISSN 1097-6825.

No.3 (September 1981), pp. 176-179, Print ISSN 0003-4738.

acetate as used in hay-fever. (1970) *Br Med J*, Vol.1, No.5691 (January 1970), pp. 267-

allergic rhinitis. (2000) *Drug Saf*, Vol.23, No.4 (October 2000), pp. 309-222, Print

Lolium perenne sublingual immunotherapy. (1997) *Allergol Immunopathol (Madr)*, Vol.25, No.5 (September-October 1997), pp. 219–227, Print ISSN 0301-0546,

intramuscular injection of methylprednisolone acetate. (1981) *Ann Allergy*, Vol.47,

Vol.26, No.3 Suppl (May 1996), pp. 18-22, Print ISSN 0105-4538, Electronic ISSN:

of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects. Clin Ther. 1996;18:1106-17. Print ISSN 0149-2918,

diagnosis and management of rhinitis. (1994) *Allergy*, Vol.49, No.19 Suppl (June

Immunomodulation during sublingual therapy in allergic children. (2003) *Pediatr Allergy Immunol*, Vol.14, No.3 (June 2003), pp. 216–221, Print ISSN 0905-6157,

term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. (1995) *J Allergy Clin Immunol*, Vol.95, No.5 Pt 2 (May 1995), pp. 1128-1132,

with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. (2010) *Pediatr Allergy Immunol*, Vol.21, No.1 Pt 2 (February 2010), pp. e160-e165, Print ISSN 0905-6157, Electronic ISSN 1399-3038. Kaszuba SM, Baroody FM, deTineo M, Haney L, Blair C, Naclerio RM. Superiority of an

intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. (2001) *Arch Int Med*, Vol.161, No.21 (November 2001), pp. 2581-2587, Print ISSN 0003-9926, Electronic ISSN 1538-3679. Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing

ocular symptoms of seasonal allergic rhinitis? (2009) *Curr Med Res Opin*, Vol.25, No.8 (August 2009), pp. 2021-2041, Print ISSN 0300-7995, Electronic ISSN 1473-

allergic rhinitis. (2011) *Am J Rhinol Allergy*, Vol.25, No.1 (January-February 2011), pp. e1-e6, Print ISSN 1945-8924, Electronic ISSN 1945-8932.


Cirla AM, Cirla PE, Parmiani S, Pecora S. A pre-seasonal birch/hazel sublingual

Cockcroft DW, MacCormack DW, Newhouse MT, Hargreave FE. Beclomethasone

Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare?

DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA. The efficacy of intranasal

Di Lorenzo G, Gervasi F, Drago A, Esposito Pellitteri M, Di Salvo A, Cosentino D, et al.

Donnelly AL, Glass M, Minkwitz MC, Casale TB. The leukotriene D4-receptor antagonist,

Durham SR, Varney VA, Gaga M, Jacobson MR, Varga EM, Frew AJ, et al. Grass pollen

Dykewicz MS, Fineman S. Executive Summary of Joint Task Force Practice Parameters on

Edwards TB. Effectiveness and safety of beclomethasone dipropionate, an intranasal

Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D, et al. Systemic immunological

2008), pp. 1120–1125, Print ISSN 0091-6749, Electronic ISSN 1097-6825.

pp. e1-e6, Print ISSN 1945-8924, Electronic ISSN 1945-8932.

(September 1976), pp. 523-526, Print ISSN 0008-4409.

pp. 331-337, Print ISSN 1088-5412, Electronic ISSN 1539-6304.

0301-0546, Electronic ISSN 1578-1267.

ISSN 0091-6749, Electronic ISSN 1097-6825.

1999), pp. 1367-1377, Electronic ISSN 1365-2222.

Electronic ISSN 1535-4970.

Electronic ISSN 1365-2222.

Electronic ISSN 1879-114X.

1534-4436.

allergic rhinitis. (2011) *Am J Rhinol Allergy*, Vol.25, No.1 (January-February 2011),

immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. (2003) *Allergol Immunopathol (Madr*), Vol.31, No.1 (January-February 2003), pp. 31–43, Print ISSN

dipropionate aerosol in allergic rhinitis. (1976) *Can Med Assoc J*, Vol.115, No.6

(1999) J *Allergy Clin Immunol*, Vol.104, No.4 Pt 1 (October 1999), pp. S144-149, Print

fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. (2003) *Allergy Asthma Proc*, Vol.24, No.5 (September-October 2003),

Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. (1999) *Clin Exp Allergy*, Vol.29, No.10 (October

ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis. (1995) *Am J Respir Crit Care Med*, Vol.151, No.6 (June 1995), pp. 1734-1739, Print ISSN 1073-449X,

immunotherapy decreases the number of mast cells in the skin. (1999) *Clin Exp Allergy*, No.29, No.11 (November 1999), pp. 1490–1496, Print ISSN 0954-7894,

Diagnosis and Management of Rhinitis. (1998) *Ann Allergy Asthma Immunol*, Vol.81, No.5 Pt 2 (November 1998), pp. 463-468, Print ISSN 1081-1206, Electronic ISSN

corticosteroid, in the treatment of patients with allergic rhinitis. (1995) *Clin Ther*, Vol.17, No.6 (November-December 1995), pp. 1032-1041, Print ISSN 0149-2918,

changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. (1999) *Int Arch Allergy Immunol*, Vol.120, No.3 (November 1999), pp. 218–124, Print ISSN 1018-2438, Electronic ISSN 1423-0097. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, et al. Grass

pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. (2008) *J Allergy Clin Immunol*, Vol.121, No.5 (May


Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy,

ISSN 0954-7894, Electronic ISSN 1365-2222.

1534-4436.

Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy 107

Lipworth BJ. Leukotriene-receptor antagonists. (1999) *Lancet*, Vol.353, No.9146 (January

Lumry WR. A review of the preclinical and clinical data of newer intranasal steroids used in

1999), pp. 57-62, Print ISSN 0140-6736, Electronic ISSN 1474-547X.

2001), pp. 505-509, Print ISSN 0001-6489, Electronic ISSN 1651-2251. Mahadevia PJ, Shah S, Leibman C, Kleinman L, O'Dowd L. Patient preferences for sensory

pp. 657–662, Print ISSN 0105-4538, Electronic ISSN 1398-9995.

0194-5998, Electronic ISSN 1097-6817.

pp. 176-179, Print ISSN 0041-6193.

Electronic ISSN 1097-6825.

responsiveness, and the late asthmatic response. (2000) *Lancet*, Vol.356, No.9248 (December 2000), pp. 2144-2148, Print ISSN 0140-6736, Electronic ISSN 1474-547X. Lima MT, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M, et al. Grass pollen

sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. (2002) *Clin Exp Allergy*, Vol.32, No.4 (April 2002), pp. 507–514, Print

the treatment of allergic rhinitis. (1999) *J Allergy Clin Immunol*, Vol.194, No.4 Pt 1 (October 1999), pp. S150-S158, Print ISSN 0091-6749, Electronic ISSN 1097-6825. Lundblad L, Sipilä P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the

treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo controlled study. (2001) *Acta Otolaryngol*, Vol.121, No.4 (June

attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. (2004) *Ann Allergy Asthma Immunol*, Vol.93, No.4 (October 2004), pp. 345–350, Print ISSN 1081-1206, Electronic ISSN

inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites. (2003) *Allergy*, Vol.58, No.7 (July 2003),

fluticasone furoate in pediatric patient with perennial allergic rhinitis. (2008) *Otolaryngol Head Neck Surg*, Vol.138, No.1 (January 2008), pp. 30-37, Print ISSN

effect on pituitary-adrenal axis. (1971) *Ulster Med J*, Vol.40, No.2 (February 1971),

safety of mometasone furoate nasal spray, amoxicillin, and placebo. (2005) *J Allergy Clin Immunol*, Vol.116, No.6 (December 2005), pp. 1289-1295, Print ISSN 0091-6749,

ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. (1999) *J Allergy Clin Immunol*, Vol.104, No.1 (July 1999),

fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. (2009) *Pediatr Allergy Immunol*, Vol.20, No.3 (May 2009), pp. 279-286, Print

nasal mucosal cells in patients with allergic rinitis. En: Intranasal fluticasone

Marcucci F, Sensi L, Frati F, Bernardini R, Novembre E, Barbato A, et al. Effects on

Máspero JF, Rosenblut A, Finn A Jr, Lim J, Wu W, Philpot E. Safety and efficacy of

McMillin WP. Triamcinoline acetonide (kenalog) in treatment of cases of hay fever and its

Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and

Meltzer EO, Berger WE, Berkowitz RB, Bronsky EA, Dvorin DJ, Finn AF et al. A dose-

Meltzer EO, Lee J, Tripathy I, Lim J, Ellsworth A, Philpot E. Efficacy and safety of once-daily

Melzer EO, Orgel HA, Kemp JP, et al. Effect of topical intranasal fluticasone propionate on

pp. 107-114, Print ISSN 0091-6749, Electronic ISSN 1097-6825.

ISSN 0905-6157, Electronic ISSN 1399-3038.

propionate. Glaxo. 1990, pp. 2-10.


Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing

Keleş N. Treatment of allergic rhinitis during pregnancy. (2004) *Am J Rhinol*, Vol.18, No.1

Kim KT, Rabinovitch N, Uryniak T, Simpson B, O'Dowd L, Casty F. Effect of budesonide

Kirchhoff CH, Kremer B, Haaf-von Below S, Kyrein HJ, Mösges R. Effects of dimethindene

Koreck AI, Csoma Z, Bodai L, Ignacz F, Kenderessy AS, Kadocsa E et al.

Kuehr J, Brauburger J, Zielen S, Schauer U, Kamin W, Von Berg A, et al. Efficacy of

La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-

LaForce CF, Dockhorn RJ, Findlay SR, Meltzer EO, Nathan RA, Stricker W, et al. Fluticasone

Laursen LC, Faurschou P, Pals H, Svendsen UG, Weeke B. Intramuscular betamethasone

pp. 61-67, Print ISSN 1081-1206, Electronic ISSN 1534-4436.

Print ISSN 0091-6749, Electronic ISSN 1097-6825.

0091-6749, Electronic ISSN 1097-6825.

6749, Electronic ISSN 1097-6825.

Electronic ISSN 1097-6825.

ISSN 0094-3509, Electronic ISSN 1533-7294.

ISSN 0300-7995, Electronic ISSN 1473-4877].

6290.

ocular symptoms of seasonal allergic rhinitis? (2010) *Curr Med Res Opin*, Vol.25, No.8 (August 2009), pp. 2021–2041, Print ISSN 0300-7995, Electronic ISSN 1473-4877 [Erratum in: (2010) *Curr Med Res Opin*, Vol.26, No.1 (January 2010), pp. 177, Print

(January-February 2004), pp. 23-28, Print ISSN 1050-6586, Electronic ISSN 1539-

aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. (2004) *Ann Allergy Asthma Immunol*,Vol.93, No.1 (July 2004),

maleate nasal spray on the quality of life in seasonal allergic rhinitis. (2003) *Rhinology*, Vol.41, No.3 (September 2003), pp.159-166, Print ISSN 03000-0729. Kopp MV, Brauburger J, Riedinger F, Beischer D, Ihorst G, Kamin W, et al. The effect of anti-

IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. (2002) *J Allergy Clin Immunol*, Vol.110,No.5 (November 2002), pp. 728-735,

Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis. (2005) *J Allergy Clin Immunol*, Vol.115, No.3 (March 2005), pp.541-547, Print ISSN

combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. (2002) *J Allergy Clin Immunol*, Vol.109, No.2 (February 2002), pp. 274-280, Print ISSN 0091-

controlled evaluation of sublingual- swallow immunotherapy with standardized *Parietaria judaica* extract in children with allergic rhinoconjunctivitis. (1999) *J Allergy Clin Immunol*, Vol.104, No.2 Pt 1 (August 1999), pp. 425–432, Print ISSN 0091-6749,

propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. (1994) *J Fam Pract*, Vol.38, No.2 (February 1994), pp. 145-152, Print

dipropionate vs. oral prednisolone in hay fever patients. (1987) *Allergy*, Vol.42, No.3 (April 1987), pp. 168-172, Print ISSN 0105-4538, Electronic ISSN: 1398-9995. Laursen LC, Faurschou P, Munch EP. Intramuscular betamethasone dipropionate vs. topical

beclomethasone dipropionate and placebo in hay fever. (1988) *Allergy*, Vol.43, No.6 (August 1988), pp. 420-424, Print ISSN 0105-4538, Electronic ISSN: 1398-9995. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an

interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-

responsiveness, and the late asthmatic response. (2000) *Lancet*, Vol.356, No.9248 (December 2000), pp. 2144-2148, Print ISSN 0140-6736, Electronic ISSN 1474-547X.


Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy,

Print ISSN 0022-1767, Electronic ISSN 1550-6606.

Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy 109

Ohlander BO, Hansson RE, Karlsson KE. A comparison of three injectable corticosteroids for

(January 1980), pp. 63-69, Print ISSN 0300-0605, Electronic ISSN 1473-2300. Olaguibel JM, Álvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory

*Clin Immunol*, Vol.15, No.1 (January 2005), pp. 9-16, Print ISSN 1018-9068. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS, et al. Randomised

Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, et al. Randomized, double-blind,

Patel RS, Shaw SR, Wallace AM, McGarry GW. Efficacy and systemic tolerability of

Pelucchi A, Chiapparino A, Mastropasqua B, Marazzini L, Hernandez A, Foresi A. Effect of

1995), pp. 515-523, Print ISSN 0091-6749, Electronic ISSN 1097-6825. Philip G, Malmstrom K, Hampel F C Jr, Weinstein S F, LaForce C F, Ratner P H, et al.

629–632, Print ISSN 0140-6736, Electronic ISSN 1474-547X.

Print ISSN 1081-1206, Electronic ISSN 1534-4436.

Print ISSN 0105-4538, Electronic ISSN: 1398-9995.

Print ISSN 0105-4538, Electronic ISSN 1398-9995.

ISSN 0091-6749, Electronic ISSN 1097-6825.

1748-5460.

blocking IgG activity. (2004) *J Immunol*, Vol.172, No.5 (March 2004), pp. 3252–3259,

the treatment of patients with seasonal hay fever. (1980) *J Int Med Res*, Vol.8, No.1

allergy in children. Conclusions from one meta-analysis. (2005) *J Investig Allergol* 

controlled trial of local allergoid immunotherapy on allergic inflammation in miteinduced rhinoconjunctivitis. (1998) *Lancet*, Vol.351, No.9103 (February 1998), pp.

placebo-controlled study of montelukast for treating perennial allergic rhinitis. (2005) *Ann Allergy Asthma Immunol*, Vol.95, No.6 (December 2005), pp. 551-557,

mometasone furoate and betamethasone sodium phosphate. (2004) *J Laryngol Otol*, Vol.118, No.11 (November 2004), pp. 866-871, Print ISSN 0022-2151, Electronic ISSN

intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens. (1995) *J Allergy Clin Immunol*, Vol.95, No.2 (February

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. (2002) *Clin Exp Allergy*, Vol.32, No.7 (July 2002), pp. 1020-1028, Print ISSN 0954-7894, Electronic ISSN 1365-2222. Pichler WJ, Klint T, Blaser M, Graf W, Sauter K, Weiss S, et al. Clinical comparison of

systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis. (1988) *Allergy*, Vol.43, No.2 (February 1988), pp. 87-92,

hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. (1988) *J Allergy Clin Immunol*, Vol.82, No.3 Pt 1 (September 1988), pp. 470–480, Print

Allergic conjunctivitis: an immunological point of view. In: Conjunctivitis - A Complex and Multifaceted Disorder. Zdenek Pelikan (Ed.) Intech Open Access

seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. (2004) *Allergy*, Vol.59, No.9 (September 2004), pp. 973–979,

Rak S, Löwhagen O, Venge P. The effect of immunotherapy on bronchial

Robles-Contreras A, Santacruz C, Ayala J, Bracamontes E, Godinez V, Estrada-García I, et al.

Publisher (Rijeka – Croatia) 2011, pp. 33-56, ISBN 978-953-307-750-5. Rolinck-Werninghaus C, Hamelmann E, Keil T, Kulig M, Koetz K, Gerstner B, et al. The co-


Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalai AA, Prillaman BA, Philpot EE.

Merck Sharp & Dohme. Ficha técnica Singulair® (montelukast sodium). Merck Sharp &

Minshall E, Ghaffar O, Cameron L, O Brien F, Quinn H, Rowe-Jones J et al. Assessment by

Modgill V, Badyal DK, Verghese A. Efficacy and safety of montelukast add-on therapy in

Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis. (1996)

Mygind N, Dahl R, Nielsen LP, Hilberg O, Bjerke T. Effect of corticosteroids on nasal

(January 2000), pp. 11-15, Print ISSN 0105-4538, Electronic ISSN: 1398-9995. Naclerio RM. Optimizing treatment options. (1998) *Clin Exp Allergy*, Vol.28, No.6 Suppl (December 1998), pp. 54-59, Print ISSN 0105-4538, Electronic ISSN: 1398-9995. Nathan RA , Berger W, Yang W, Cheema A, Silvey MJ, Wu W, Philpot E. Effect of once-daily

2008), pp. 497–505, Print ISSN 1081-1206, Electronic ISSN 1534-4436. Nayak A, Casale TB, Miller SD, Condemi J, McAlary M, Fowler-Taylor A, et al. Tolerability

323–329, ISSN Print 1088-5412, Electronic ISSN 1539-6304.

No.1 (January 2003), pp. 55-65, Print ISSN 1175-6365.

ISSN 0027-8424, Electronic ISSN 1091-6490.

Dohme Corp., US Patent No.:5,565,473. Revised: 09/2011.

pp. 669-674, Print ISSN 0379-0355, Electronic ISSN 2013-0155.

114X.

6817.

Electronic ISSN: 1398-9995.

Preferences of Adult Patients with Allergic Rhinitis for the Sensory Attributes of Fluticasone Furoate Versus Fluticasone Propionate Nasal Sprays: A Randomized, Multicenter, Double-Blind, Single-Dose, Crossover Study. (2008) *Clin Ther*, Vol.30, No.2 (February 2008), pp. 271–279, Print ISSN 0149-2918, Electronic ISSN 1879-

nasal biopsy of long-time use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. (1998) *Otolaryngol Head Neck Surg*, Vol.118, No.5 (May 1998), pp. 648-654, Print ISSN 0194-5998, Electronic ISSN 1097-

allergic rhinitis. *Methods Find Exp Clin Pharmacol*, Vol.32, No.9 (November 2010),

*Clin Exp Allergy*, Vol.26, No.3 Suppl (May 1996), pp. 2-10, Print ISSN 0105-4538,

blockage in rhinitis measured by objective methods. (1997) *Allergy*, Vol.52, No.40 Suppl (January 1997), pp. 39-44, Print ISSN 0105-4538, Electronic ISSN: 1398-9995. Mygind N, Laursen LC, Dahl M. Systemic corticosteroid treatment for seasonal allergic

rhinitis: a common but poorly documented therapy. (2000) *Allergy*, Vol.55, No.1

fluticasone furoate nasal spray on nasal symptoms in adults andadolescents with perennial allergic rhinitis. (2008) *Ann Allergy Asthma Immunol*, Vol.100, No.5 (May

of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis. (2003) *Allergy Asthma Proc*, Vol.24, No.5 (September-October 2003), pp.

genetically engineered allergens prevents progression of allergic disease. (2004) *Proc Natl Acad Sci USA*, Vol.101, No. Suppl. 2 (October 2004), pp. 14677–1482, Print

rhinitis: a review of randomized, controlled trials. (2003) *Am J Respir Med*, Vol.2,

Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and

Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P, et al. Vaccination with

Nielsen LP, Dahl R. Comparison of intranasal corticosteroids and antihistamines in allergic

Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, et al.

blocking IgG activity. (2004) *J Immunol*, Vol.172, No.5 (March 2004), pp. 3252–3259, Print ISSN 0022-1767, Electronic ISSN 1550-6606.


Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy,

ISSN 0277-0903, Electronic ISSN 1532-4303.

ISSN 0301-0546, Electronic ISSN 1578-1267.

ISSN 1097-6825.

Electronic ISSN 1578-1267.

6749, Electronic ISSN 1097-6825.

0008, Electronic ISSN 1875-9114.

Print ISSN 0001-6489.

Electronic ISSN 1398-9995.

0105-4538, Electronic ISSN 1398-9995.

Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy 111

Stjarne P, Blomgren K, Caye-Thomasen P, Salo S, Soderstrom T. The efficacy and safety of

Szefler SJ. Pharmacokinetics of intranasal corticosteroids. (2001) *J Allergy Clin Immunol*,

Taramarcaz P, Gibson PG. The effectiveness of intranasal corticosteroids in combined

Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with

Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. (2004) *J* 

Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N, et al. Allergic

Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. (2002)

Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effect of botulinum toxin type A on nasal

Van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, et al.

Van Cauwenberge P. ARIA: impact of compliance. (2005) *Clin Exp Allergy Rev*, Vol.5, No.1

Van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica G, Durham S et al.

(August 2005), pp. 3-6, Electronic ISSN 1472-9733.

2006), pp. 606-612, Print ISSN 0001-6489, Electronic ISSN 1651-2251. Storms WW. Risk-benefit assessment of fluticasone propionate in the treatment of asthma

once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. (2006) *Acta Otolaryngol*, Vol.126, No.6 (June

and allergic rhinitis. (1998) *J Asthma*, Vol.35, No.4 (April 1998), pp. 313-336, Print

Vol.108, No.1 Suppl (January 2001), pp. S26-S31. Print ISSN 0091-6749, Electronic

allergic rhinitis and asthma syndrome. (2004) *Clin Exp Allergy*, Vol.34, No.12 (December 2004), pp. 1883-1889, Print ISSN 0954-7894, Electronic ISSN 1365-2222. Tari MG, Mancino M, Madonna F, Buzzoni L, Parmiani S. Immunologic evaluation of 24

month course of sublingual immunotherapy. (1994) *Allergol Immunopathol (Madr)*, Vol.22, No.5 (September-October 1994), pp. 209–216, Print ISSN 0301-0546,

rhinitis and asthma due to house dust mite. A double-blind study. (1990) *Allergol Immunopathol (Madr)*, Vol.18, No.5 (September-October 1990), pp. 277–284, Print

*Allergy Clin Immunol*, Vol.113, No.6 (June 2004), pp. 1025–1034, Print ISSN 0091-

rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. (2004) *Allergy*, Vol.59, No.5 (May 2004), pp. 491-497, Print ISSN

*Pharmacotherapy*, Vol.22, No.11 (November 2002), pp. 1458-1467, Print ISSN 0277-

symptoms in patients with allergic rhinitis: a double blind, placebo-controlled clinical trial. (2003) *Acta Otolaryngol*, Vol.123, No.9 (December 2003), pp. 1060-1063,

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. (2003) *Ann Allergy Asthma Immunol*, Vol.90, No.2 (February 2003), pp. 214-222, Print ISSN 1081-1206, Electronic ISSN 1534-4436.

Consensus statement on the treatment of allergic rhinitis. EAACI Position paper. (2000) *Allergy*, Vol.55, No.2 (February 2000), pp. 116-134, Print ISSN 0105-4538,


Rosenblut A, Bardin PG, Muller B, Faris MA, Wu W, Caldwell MF, et al. Long-term safety of

Saengpanich S, deTineo M, Naclerio RM, Baroody FM. Fluticasone nasal spray and the

Salib RJ, Howarth PH. Safety and tolerability profiles of intranasal antihistamines and

Scadding GK, Darby YC, Austin CE. Effect of short-term treatment with fluticasone

Schenkel E, Skoner D, Bronsky E, Miller SD, Pearlman DS, Rooklin A et al. Absence of

Schultz A, Stuck BA, Feuring M, Hörmann K, Wehling M. Novel approaches in the

(February 2003), pp. 21-27, Print ISSN 1528-4050, Electronic ISSN 1473-6322. Scow DT, Luttermoser GK, Dickerson KS. Leukotriene inhibitors in the treatment of allergy

Shamji MH, Wilcock LK, Wachholz PA, Dearman RJ, Kimber I, Wurtzen PA, et al. The IgE-

Shiung YY, Chiang CY, Chen JB, Wu PC, Hung AF, Lu DC, et al. An anti-IgE monoclonal

Small CB, Hernandez J, Reyes A, Schenkel E, Damiano A, Stryszak P et al. Efficacy and

Smith H, White P, Annila I, Poole J, Andre C, Frew A. Randomized controlled trial of high-

Vol.26, No.12 (November 2003), pp. 863-893, Print ISSN 0114-5916.

0105-4538, Electronic ISSN 1398-9995.

4470, Electronic ISSN 1538-361X.

Electronic ISSN 1365-2125.

pp. 313-320, Print ISSN 0009-9090.

Electronic ISSN 1872-7905.

Electronic ISSN 1097-6825.

Electronic ISSN 1097-6825.

ISSN 1878-3279.

ISSN 0002-838X, Electronic ISSN 1532-0650.

fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. (2007) *Allergy*, Vol.62, No.9 (September 2007), pp. 1071–1077, Print ISSN

combination of loratadine and montelukast in seasonal allergic rhinitis. (2003) *Arch Otolaryngol Head Neck Surg*, Vol.129, No.5 (May 2003), pp. 557-562, Print ISSN 0886-

intranasal corticosteroids in the treatment of allergic rhinitis. (2003) *Drug Saf*,

propionate nasal spray on the response to nasal allergen challenge. (1994) *Br J Clin Pharmacol*, Vol.38, No.5 (November 1994), pp. 447-451, Print ISSN 0306-5251,

growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. (2000) *Pediatrics*, Vol.105, No.2 (February 2000), pp. E22, Print ISSN 0031-4005, Electronic ISSN 1098-4275. Schulz JI, Johnson JD, Freedman SO. Double-blind trial comparing flunisolide and placebo

for the treatment of perennial rhinitis. (1978) *Clin Allergy*, Vol.8, No.4 (July 1978),

treatment of allergic rhinitis. (2003) *Curr Opin Allergy Clin Immunol*, Vol.3, No.1

and asthma. (2007) Am Fam Physician, Vol.75, No.1 (January 2007), pp. 65-70, Print

facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. (2006) *J Immunol Methods*, Vol.317, No.1-2 (December 2006), pp. 71–79, Print ISSN 0022-1759,

antibody that binds to IgE on CD23 but not on high-affinity IgE Fc receptors. (2001) *Immunobiology*, 2011 Nov 25. [Epub ahead of print], Print ISSN 0171-2985, Electronic

safety of mometasone furoate nasal spray in nasal polyposis. (2005) *J Allergy Clin Immunol*, Vol.116, No.6 (December 2005), pp. 1275-1281, Print ISSN 0091-6749,

dose sublingual immunotherapy to treat seasonal allergic rhinitis. (2004) *J Allergy Clin Immunol*, Vol.114, No.4 (October 2004), pp. 831–837, Print ISSN 0091-6749,


**Section 3** 

**Laryngology** 

